ADPT Sale Disclosure
Bobulsky Susan · SEC Form 4 · Filed Jul 20, 2026
Sale
Calculated transaction value
$115K
Bobulsky Susan Chief Commercial Officer, Mrd
Transaction date
Jul 16, 2026
Public filing date
Jul 20, 2026
Filing lag
Filed 4 days later
ADPT daily price context
Close on/before transaction
$22.1
Jul 16, 2026
Close before public filing
$22.92
Jul 17, 2026
Return since public filing
+7.2%
Through Sep 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,000 shares @ $23
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001820885-26-000016
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$115K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Adaptive Biotechnologies Corp ADPT Current | Sale | Jul 16, 2026 | $115K |